ID

20232

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Stichworte

Versionen (2)
  1. 15.02.17 15.02.17 -
  2. 20.02.17 20.02.17 -
Hochgeladen am

15. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Englisch

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare  
Events
Beschreibung

Events

Alias
UMLS CUI-1
C0877248
1. Has the patient experienced any of the following since randomization:
Beschreibung

Patient experience

Datentyp

text

Dizziness or Lightheadedness
Beschreibung

Dizziness or Lightheadedness

Datentyp

boolean

Fainting
Beschreibung

Fainting

Datentyp

boolean

Alias
UMLS CUI [1]
C0039070
Headache during first week of study drug administration
Beschreibung

Headache

Datentyp

boolean

If headache occurred please indicate how it was treated (indicate all that apply):
Beschreibung

If headache

Datentyp

integer

2. Have any Outcome Events or Serious Adverse Events been experienced? (See instructions on facing page)
Beschreibung

Outcome Events or Serious Adverse Events

Datentyp

boolean

if "Yes" please indicate all that apply
Beschreibung

If Yes

Datentyp

integer

Please complete the respective forms
Beschreibung

Please complete the respective forms

4. Signature of Investigator or Sub-Investigator
Beschreibung

By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient visit; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.

Datentyp

text

Date of Signature (dd mon yy)
Beschreibung

Date of Signature

Datentyp

date

Zum Seitenanfang zurückkehren

Ähnliche Modelle

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Events
C0877248 (UMLS CUI-1)
Patient experience
Item
1. Has the patient experienced any of the following since randomization:
text
Dizziness or Lightheadedness
Item
Dizziness or Lightheadedness
boolean
Fainting
Item
Fainting
boolean
C0039070 (UMLS CUI [1])
Headache
Item
Headache during first week of study drug administration
boolean
Item
If headache occurred please indicate how it was treated (indicate all that apply):
integer
If headache
Code List
If headache occurred please indicate how it was treated (indicate all that apply):
CL Item
Analgestic (1)
CL Item
Down titration of study medication A (2)
CL Item
No treatment (3)
Outcome Events or Serious Adverse Events
Item
2. Have any Outcome Events or Serious Adverse Events been experienced? (See instructions on facing page)
boolean
Item
if "Yes" please indicate all that apply
integer
If Yes
Code List
if "Yes" please indicate all that apply
CL Item
Stroke (1)
CL Item
Myocardial Infarction (2)
CL Item
Death (3)
CL Item
New or worsening congestive heart failure (CHF) (4)
CL Item
Other designated vascular event (5)
CL Item
Hemorrhagic Event (6)
CL Item
Thrombotic Thrombocytopenia purpura (7)
CL Item
Neutropenia (8)
CL Item
Newly diagnosed diabetes (9)
Item Group
Please complete the respective forms
Signature of Investigator or Sub-Investigator
Item
4. Signature of Investigator or Sub-Investigator
text
Date of Signature
Item
Date of Signature (dd mon yy)
date
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video